Liabilities and Equity of BIO-RAD LABORATORIES, INC. from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
BIO-RAD LABORATORIES, INC. quarterly Liabilities and Equity in USD history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • BIO-RAD LABORATORIES, INC. Liabilities and Equity for the quarter ending 31 Dec 2025 was $10,576,500,000, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $10,576,500,000 +$1,212,400,000 +13% 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q3 2025 $9,696,400,000 -$907,072,000 -8.6% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $10,214,100,000 +$525,654,000 +5.4% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $9,526,900,000 -$3,082,993,000 -24% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $9,364,100,000 -$2,935,000,000 -24% 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q3 2024 $10,603,472,000 -$1,292,471,000 -11% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $9,688,446,000 -$2,289,783,000 -19% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $12,609,893,000 -$1,057,521,000 -7.7% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $12,299,100,000 -$1,202,566,000 -8.9% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $11,895,943,000 -$162,519,000 -1.3% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $11,978,229,000 -$703,897,000 -5.6% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $13,667,414,000 -$706,284,000 -4.9% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $13,501,666,000 -$4,297,727,000 -24% 31 Dec 2022 10-K 16 Feb 2024 2023 FY
Q3 2022 $12,058,462,000 -$7,894,918,000 -40% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $12,682,126,000 -$2,435,430,000 -16% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $14,373,698,000 +$440,538,000 +3.2% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $17,799,393,000 +$4,826,775,000 +37% 31 Dec 2021 10-K 17 Feb 2023 2022 FY
Q3 2021 $19,953,380,000 +$7,932,449,000 +66% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $15,117,556,000 +$5,020,249,000 +50% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $13,933,160,000 +$5,248,801,000 +60% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $12,972,618,000 +$4,963,759,000 +62% 31 Dec 2020 10-K 11 Feb 2022 2021 FY
Q3 2020 $12,020,931,000 +$4,843,815,000 +67% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $10,097,307,000 +$2,450,362,000 +32% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $8,684,359,000 +$1,821,445,000 +27% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $8,008,859,000 +$2,397,791,000 +43% 31 Dec 2019 10-K 16 Feb 2021 2020 FY
Q3 2019 $7,177,116,000 +$458,454,000 +6.8% 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 $7,646,945,000 +$1,260,722,000 +20% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $6,862,914,000 +$648,002,000 +10% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $5,611,068,000 +$1,338,056,000 +31% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $6,718,662,000 +$2,532,934,000 +61% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 $6,386,223,000 +$2,242,764,000 +54% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $6,214,912,000 +$2,262,143,000 +57% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $4,273,012,000 +$422,508,000 +11% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $4,185,728,000 +$166,002,000 +4.1% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $4,143,459,000 +$268,824,000 +6.9% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 $3,952,769,000 +$199,356,000 +5.3% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 $3,850,504,000 +$140,786,000 +3.8% 31 Dec 2016 10-K 16 Apr 2018 2017 FY
Q3 2016 $4,019,726,000 +$353,330,000 +9.6% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 $3,874,635,000 +$349,292,000 +9.9% 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 $3,753,413,000 +$427,217,000 +13% 31 Mar 2016 10-Q 06 May 2016 2016 Q1
Q4 2015 $3,709,718,000 +$368,440,000 +11% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 $3,666,396,000 +$280,372,000 +8.3% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $3,525,343,000 +$57,592,000 +1.7% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 $3,326,196,000 -$115,182,000 -3.3% 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q4 2014 $3,341,278,000 -$47,512,000 -1.4% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 $3,386,024,000 +$105,616,000 +3.2% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 $3,467,751,000 -$15,070,000 -0.43% 30 Jun 2014 10-Q 06 Aug 2014 2014 Q2
Q1 2014 $3,441,378,000 -$15,425,000 -0.45% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 $3,388,790,000 -$54,713,000 -1.6% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q3 2013 $3,280,408,000 -$22,608,000 -0.68% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 $3,482,821,000 +$313,926,000 +9.9% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 $3,456,803,000 +$268,929,000 +8.4% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 $3,443,503,000 +$346,700,000 +11% 31 Dec 2012 10-K 18 Mar 2014 2013 FY
Q3 2012 $3,303,016,000 +$333,221,000 +11% 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 $3,168,895,000 +$124,650,000 +4.1% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 $3,187,874,000 +$279,101,000 +9.6% 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 $3,096,803,000 +$34,039,000 +1.1% 31 Dec 2011 10-K 18 Mar 2013 2012 FY
Q3 2011 $2,969,795,000 +$287,591,000 +11% 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 $3,044,245,000 +$517,121,000 +20% 30 Jun 2011 10-Q 04 Aug 2011 2011 Q2
Q1 2011 $2,908,773,000 31 Mar 2011 10-Q 06 May 2011 2011 Q1
Q4 2010 $3,062,764,000 31 Dec 2010 10-K 29 Feb 2012 2011 FY
Q3 2010 $2,682,204,000 30 Sep 2010 10-Q 09 Nov 2010 2010 Q3
Q2 2010 $2,527,124,000 30 Jun 2010 10-Q 06 Aug 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.